Currently out of the existing stock ratings of Jasper Hellweg, 105 are a BUY (94.59%), 6 are a HOLD (5.41%).

Jasper Hellweg

Work Performance Price Targets & Ratings Chart

Analyst Jasper Hellweg, currently employed at ARGUS, carries an average stock price target met ratio of 83.47% that have a potential upside of 16.27% achieved within 257 days.

Jasper Hellweg’s has documented 219 price targets and ratings displayed on 30 stocks. The coverage is on Healthcare, Industrials, Technology sectors.

Most recent stock forecast was given on ITGR, Integer Holdings Corp at 23-Oct-2025.

Wall Street Analyst Jasper Hellweg

Analyst best performing recommendations are on MRNA (MODERNA).
The best stock recommendation documented was for MRNA (MODERNA) at 11/11/2020. The price target of $88 was fulfilled within 2 days with a profit of $5.56 (6.74%) receiving and performance score of 33.72.

Average potential price target upside

of $85 (13.87%) on REGN (REGENERON PHARMACEUTICALS).
of $70.1 (20.46%) on ELV (ELEVANCE HEALTH).
of $53.61 (15.13%) on ANTM (ANTHEM).

ANTM Anthem ILMN Illumina MDRX Allscripts Healthcare Solutions MRNA Moderna REGN Regeneron Pharmaceuticals TEVA Teva Pharma Industries Ltd ADR ZTS Zoetis CERN Cerner Corp IQV IQVIA Holdings ITGR Integer Holdings Corp LH Laboratory of America Holdings VRTX Vertex Pharmaceuticals HCA HCA Holdings ELV Elevance Health GILD Gilead Sciences UTHR United Therapeutics ABBV AbbVie AZN AstraZeneca PLC ADR BIIB Biogen BSX Boston Scientific Corp INCY yte NVO Novo Nordisk A/S SNY Sanofi ADR DGX Quest Diagnostics EBS Emergent Biosolutions EFX Equifax FISV Fiserv LGND Ligand Pharmaceuticals MYL Viatris VTRS Viatris

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Ricky Goldwasser (MORGAN STANLEY)